Anti saccharomyces cerevisiae antibodies

Additional recommended knowledge

Daily Sensitivity Test

Correct Test Weight Handling Guide: 12 Practical Tips

How to quickly check pipettes?

Anti Saccharomyces cerevisiae antibodies (ASCA).ASCA antibodies along with perinuclear antineutrophil cytoplasmic antibodies (pANCA) are among the two most useful and often discriminating markers for colitis.^[1] ASCA tends to recognize Crohn's disease more frequently, whereas pANCA tend to recognize ulcerative colitis.^[2]

ASCA antibodies react to the following yeast proteins

• Mannans^[3]
  • 200 kDA glycoprotein.^[4]

Diseases in which ASCA are found:

• Behçet's disease^[5] - The association with ASCA is not generally strong, but increased in patients with gastrointestinal symptoms.^[6]
• Celiac disease^[7][8]
• Colitis^[7]
  • Ulcerative colitis-familial.^[9]
  • Microscopic colitis
    • Collagenous colitis^[10]
• Crohn's disease^[11][12]

  Intestinal yeast and ASCA+. Intestinal yeast infections are seen in malabsorptive diseases like coeliac disease. In Crohn's disease and ulcerative colitis the presence of intestinal S. cerevisiae is rare, but the association with irritiable bowel in coeliac disease remains unstudied.^[13]

Anti-mannans

  Mannan (oligomannin) is a component of the yeast cell wall. Antibodies to yeast mannans are found at increased frequency in Crohn's disease and ASCA+ Crohn's tend to have lower low levels of mannan-binding lectin.^[14] Experimentally, antibodies to mannans from yeast can also crossreact to mannans of other types of yeast.^[15] Study of the sugars indicated that a mannotetraose (4-mer) was responsible for highest response. ^[16] Studies of the 200 kDa glycoprotein antibodies found them commonly in healthy people, suggesting that the disease associated antibodies are to their carbohydrate moieties. ^[17] Mannans from other yeast, for example candida albicans, have found to cross react with ASCA which suggests that other yeast may induce ASCA associated diseases.

Mannan-binding lectin (MBL) is a lectin produced by humans. In ASCA+ Crohn's disease the serum level of this protein is lower. Cellular response to mannan in ASCA+ peripheral blood lymphocytes could be inhibited by adding MBL, however, a high frequency of mutations in the MBL gene was found in ASCA+ patients.^[18]

Crohn's disease

ASCA are consistently higher in frequency in Crohn's disease. Yeast cause a three-fold increase in lymphocyte proliferation relative to normal controls.^[19] The ASCA antibodies are also more frequently found in familial Crohn's disease.^[9] An altered humoral and cellular response to mannan is observed and may be due to a loss of yeast tolerance.^[20] This alteration is marked by increased activation markers, CD25/CD69, upon proliferative stimulation of T-helper lymphocytes. ASCA+ is a predictor for Chrohn's disease with high specificity and positive predictive value (87% and 78% repsectively). ASCA are associated with proximal (gastroduodenal and small bowel involvement) rather than purely colonic disease (P < 0.001) and with a more severe disease phenotype and requirement for surgery over a median follow-up time of 9 years (P < 0.0001). There is no association between genetic markers for Crohn's disease and NOD2/CARD15 or MP (IgA or IgG) indicating heterogeneous causes for Crohn's disease^[21]. [Note: CD is a common abbreviation for Crohn's disease. It is more commonly used for coeliac disease which may be primary to some forms of colitis. When reviewing abstracts for colitis, it is important to note the abbreviation is used for both.]

References